Mobile Technology for Reducing and Preventing Adolescent Suicide
NCT ID: NCT04896593
Last Updated: 2023-03-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2021-07-12
2022-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Trial of Mobile Technology for Adolescent Suicidality
NCT06454136
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury
NCT07224165
A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients
NCT05486091
An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART
NCT03838198
Just-in-time Interventions for Reducing Short-term Suicide Risk
NCT05793541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Smartphone app teaching suicide prevention skills.
Smartphone App
Smartphone app teaching suicide prevention skills.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smartphone App
Smartphone app teaching suicide prevention skills.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand written and spoken English
* Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
* Willing and able to complete enrollment procedures
* Parent/guardian (and youth) able to understand the nature of the study and provide written informed consent (assent for youth)
* Willing to agree to release of information to their parent/guardian and providers when clinically indicated.
* Discharge plan includes aftercare within the Hartford HealthCare system (to facilitate coordination of care during follow up)
Exclusion Criteria
* Patients experiencing substance withdrawal
* Currently enrolled in other treatment studies for the symptoms and behaviors targeted
* Patient unwilling or unable to wear mask during in-person study procedures
* Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit profile with respect to the Smartphone App.
* Any other psychiatric or medical condition (e.g., intellectual disability) or custody arrangement that in the investigator's opinion would preclude informed consent/assent or participation in the trial.
13 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oui Therapeutics, Inc.
INDUSTRY
National Institute of Mental Health (NIMH)
NIH
Hartford Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Tolin, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Institute of Living/Hartford Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Living/Hartford Hospital
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HHC-2020-0363
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.